- Summary
- Stats & Ratios
- Income Statement
- Balance Sheet
- Cash Flow
- Opinions
ImaRx Therapeutics, Inc.
(NASDAQ:IMRX)- View:
- Quarterly Data
- Annual Data
- Note: All numbers in thousands
| Sep 30, 2008 | Jun 30, 2008 | Mar 31, 2008 | Dec 31, 2007 | |
|---|---|---|---|---|
| Assets | ||||
| Current Assets | ||||
| Cash & Equivalents | 2,439 | 2,146 | 10,293 | 12,861 |
| Restricted Cash | — | — | — | 388 |
| Marketable Securities | — | — | — | — |
| Accounts Receivable | — | 28 | 124 | 349 |
| Loans Receivable | — | — | — | — |
| Other Receivable | — | — | — | — |
| Receivables | — | 28 | 124 | 349 |
| Raw Materials | — | — | — | — |
| Work in Progress | — | — | — | — |
| Purchased Components | — | — | — | — |
| Finished Goods | — | — | — | — |
| Other Inventories | 587 | 3,809 | 12,935 | 13,698 |
| Inventories Adjustments and Allowances | — | — | — | — |
| Inventories | 587 | 3,809 | 12,935 | 13,698 |
| Prepaid Expenses | 208 | 201 | — | 589 |
| Current Deferred Income Taxes | — | — | 320 | — |
| Other Current Assets | 108 | 279 | — | — |
| Total Current Assets | 3,342 | 6,463 | 23,672 | 27,885 |
| Land and Improvements | — | — | — | — |
| Building and Improvements | — | — | — | 652 |
| Machinery Furniture and Equipment | — | — | 1,046 | 2,648 |
| Construction in Progress | — | — | — | 43 |
| Other Fixed Assets | 2,243 | 2,285 | 2,173 | — |
| Total Fixed Assets | 2,243 | 2,285 | 3,219 | 3,343 |
| Gross Fixed Assets | 2,243 | 2,285 | 3,219 | 3,343 |
| Accumulated Depreciation and Depletion | 2,173 | 2,173 | 2,173 | 2,173 |
| Net Fixed Assets | 70 | 112 | 1,046 | 1,170 |
| Intangibles | — | — | 1,459 | 1,633 |
| Cost in Excess | — | — | — | — |
| Non Current Deferred Income Taxes | — | — | — | — |
| Other Non Current Assets | — | — | 19 | 19 |
| Total Non Current Assets | 70 | 112 | 2,524 | 2,822 |
| Total Assets | 3,412 | 6,575 | 26,196 | 30,707 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payable | 1,373 | 1,459 | 1,213 | 1,277 |
| Notes Payable | — | — | 10,749 | 11,698 |
| Short Term Debt | — | — | — | — |
| Accrued Expenses | 203 | 591 | 593 | 837 |
| Accrued Liabilities | — | 1,069 | 1,251 | 1,317 |
| Deferred Revenues | 1,194 | 2,640 | 4,471 | 5,373 |
| Current Deferred Income Tax Liabilities | — | — | — | — |
| Other Current Liabilities | 187 | 247 | 40 | — |
| Total Current Liabilities | 2,957 | 6,006 | 18,317 | 20,502 |
| Non Current Liabilities | ||||
| Long Term Debt | — | — | — | — |
| Capital Lease Obligations | — | — | — | — |
| Deferred Income Tax Liabilities | — | — | — | — |
| Other Non Current Liabilities | — | — | — | — |
| Minority Interest Liabilities | — | — | — | — |
| Preferred Securities of Subsidiary Trust Liabilities | — | — | — | — |
| Preferred Equity Outside Stock Equity | — | — | — | — |
| Total Non Current Liabilities | 2,957 | 6,006 | 18,317 | 20,502 |
| Total Liabilities | — | — | — | — |
| Shareholders' Equity | ||||
| Preferred Stock Equity | — | — | — | — |
| Common Stock Equity | 455 | 569 | 7,879 | 10,205 |
| Common Par | 1 | 1 | 1 | 1 |
| Additional Paid in Capital | 91,652 | 91,550 | 91,590 | 91,386 |
| Cumulative Translation Adjustment | — | — | — | — |
| Retained Earnings | -91,198 | -90,982 | -83,712 | -81,182 |
| Treasury Stock | — | — | — | — |
| Other Equity Adjustments | — | — | — | — |
| Total Capitalization | 455 | 569 | 7,879 | 10,205 |
| Cash Flow | -11,410 | -22,629 | -17,155 | -17,380 |
| Working Capital | 385 | 457 | 5,355 | 7,383 |
| Free Cash Flow | -6,511 | -4,804 | -1,834 | 1,361 |
| Invested Capital | 455 | 569 | 7,879 | 10,205 |
| Total Equity | 455 | 569 | 7,879 | 10,205 |
| Total Liabilities and Stock Equity | 3,412 | 6,575 | 26,196 | 30,707 |